Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Induced Pluripotent Stem Cells01:13

Induced Pluripotent Stem Cells

28.2K
Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore...
28.2K
Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

5.7K
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
5.7K
CRISPR01:59

CRISPR

58.1K
Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...
58.1K
CRISPR/Cas9 Genome Editing01:28

CRISPR/Cas9 Genome Editing

2.0K
The CRISPR-Cas system serves as a bacterial defense mechanism against invading genetic elements such as viruses and plasmids, forming the foundation for its adaptation as a powerful genome-editing tool. Originally discovered in prokaryotes, this system has been repurposed to revolutionize genetic engineering across a wide range of organisms, including plants, animals, and humans. The core component, Cas9, is an endonuclease derived from Streptococcus pyogenes, capable of introducing...
2.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Human Multi-Organ-on-a-Chip Platforms for Next-Generation Drug Delivery Strategies.

Theranostics·2026
Same author

Immune-competent new approach methodologies for a hybrid future.

Nature immunology·2026
Same author

Label-free volumetric refractive-index imaging of fibrillar collagen architecture, assembly, and cell-associated remodeling.

bioRxiv : the preprint server for biology·2026
Same author

Toward bioengineered muscle-fat microphysiological systems for sports medicine and obesity therapeutics.

Advanced drug delivery reviews·2026
Same author

Deep-learning-enabled morphodynamic analysis of drug responses in a biomimetic fibrin-based 3D glioblastoma invasion model.

bioRxiv : the preprint server for biology·2026
Same author

Nanopatterned Cell Sheet Assembly of Biomimetic Cardiac Laminae for Modeling Structure-Function Relationships.

Biomaterials research·2026

Related Experiment Video

Updated: Feb 18, 2026

Generation of Defined Genomic Modifications Using CRISPR-CAS9 in Human Pluripotent Stem Cells
09:04

Generation of Defined Genomic Modifications Using CRISPR-CAS9 in Human Pluripotent Stem Cells

Published on: September 25, 2019

8.8K

CRISPR Genome Engineering for Human Pluripotent Stem Cell Research.

Somali Chaterji1, Eun Hyun Ahn2,3, Deok-Ho Kim4,3,5

  • 1Department of Computer Science, Purdue University, West Lafayette, IN 47907, USA.

Theranostics
|November 22, 2017
PubMed
Summary

Genome editing technologies like CRISPR-Cas offer precise cell engineering, building on RNA-interference (RNA-i) therapy lessons. Overcoming challenges in delivery and bioinformatics is key for translating these powerful tools from the lab to the clinic.

More Related Videos

Establishment of Genome-edited Human Pluripotent Stem Cell Lines: From Targeting to Isolation
09:51

Establishment of Genome-edited Human Pluripotent Stem Cell Lines: From Targeting to Isolation

Published on: February 2, 2016

14.2K
Genome Editing and Directed Differentiation of hPSCs for Interrogating Lineage Determinants in Human Pancreatic Development
09:37

Genome Editing and Directed Differentiation of hPSCs for Interrogating Lineage Determinants in Human Pancreatic Development

Published on: March 5, 2017

13.6K

Related Experiment Videos

Last Updated: Feb 18, 2026

Generation of Defined Genomic Modifications Using CRISPR-CAS9 in Human Pluripotent Stem Cells
09:04

Generation of Defined Genomic Modifications Using CRISPR-CAS9 in Human Pluripotent Stem Cells

Published on: September 25, 2019

8.8K
Establishment of Genome-edited Human Pluripotent Stem Cell Lines: From Targeting to Isolation
09:51

Establishment of Genome-edited Human Pluripotent Stem Cell Lines: From Targeting to Isolation

Published on: February 2, 2016

14.2K
Genome Editing and Directed Differentiation of hPSCs for Interrogating Lineage Determinants in Human Pancreatic Development
09:37

Genome Editing and Directed Differentiation of hPSCs for Interrogating Lineage Determinants in Human Pancreatic Development

Published on: March 5, 2017

13.6K

Area of Science:

  • Molecular Biology
  • Genetics
  • Biotechnology

Background:

  • Genome editing technologies, including CRISPR-Cas systems, have advanced cell engineering.
  • Lessons from RNA-interference (RNA-i) therapies can guide the translation of genome editing.
  • Bacterial nucleases are being repurposed for precise genome modification.

Purpose of the Study:

  • To review the opportunities and challenges of repurposing bacterial nucleases for genome editing.
  • To highlight the role of genome editing at the epigenomic level.
  • To discuss the translation of human pluripotent stem cell engineering.

Main Methods:

  • Review of high-precision genome editing technologies, focusing on CRISPR-Cas9.
  • Analysis of challenges in bench-to-bedside translation.
  • Examination of complementary technologies like RNA-i for translational insights.

Main Results:

  • CRISPR-Cas9 and similar programmable nucleases enable precise targeting in human stem cells.
  • Significant challenges remain for clinical translation of genome editing technologies.
  • Bioinformatics and delivery vehicle development are crucial for overcoming hurdles.

Conclusions:

  • Repurposed bacterial nucleases hold immense potential for revolutionizing human stem cell technologies.
  • Learning from RNA-i therapy translation is vital for advancing genome editing clinical applications.
  • Further development in bioinformatics and delivery systems is necessary for successful clinical implementation.